Drugs / NBP606
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02927444 | Nov 2015 → Oct 2017 | pneumococcal infection | SK Chemicals Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT02201030 | Sep 2014 → Oct 2016 | pneumococcal infection | SK Chemicals Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT02079207 | Dec 2013 → Oct 2014 | pneumococcal infection | SK Chemicals Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NBP606 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02079207 ↗ |
| Route | Intramuscular | “A single intramuscular injection into the thigh” NCT02201030 ↗ |